serum institute
Jump to
17 Results Found
  • Covid vaccine production and availability: What we know so far May 04, 2021 02:23 PM IST

    Covid vaccine production and availability: What we know so far

    So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.

  • COVID-19 vaccine | Serum Institute's Covishield priced at Rs 400 per dose for states; Rs 600/dose for private hospitals Apr 21, 2021 12:42 PM IST

    COVID-19 vaccine | Serum Institute's Covishield priced at Rs 400 per dose for states; Rs 600/dose for private hospitals

    Serum Institute of India said 50 percent of its capacities will serve the Centre's COVID-19 vaccination programme, and the remaining 50 percent will be for state governments and private hospitals.

  • COVID-19 vaccine | Serum's Covishield, Bharat Biotech's Covaxin 'not considered' for emergency use authorisation: Sources Dec 09, 2020 05:51 PM IST

    COVID-19 vaccine | Serum's Covishield, Bharat Biotech's Covaxin 'not considered' for emergency use authorisation: Sources

    Both Bharat Biotech and Serum Institute of India have been asked by the Subject Expert Committee to furnish more data, trial information, and documents

  • Bill Gates hails India's digital finance approach, calls it 'global model' Dec 08, 2020 04:21 PM IST

    Bill Gates hails India's digital finance approach, calls it 'global model'

    Gates praised India for building ambitious platforms for universal identification and digital payments which include the world’s largest biometric database and a system for sending rupees between any bank or smartphone app.

  • Big Story | Serum Institute to seek Rs 100 crore In damages from vaccine volunteer: A look at Covishield legal row Nov 30, 2020 05:37 PM IST

    Big Story | Serum Institute to seek Rs 100 crore In damages from vaccine volunteer: A look at Covishield legal row

    The 40-year-old volunteer claimed that he contracted severe neurological disorders after being vaccinated with Covidshield shots under development at Serum Institute of India. All you need to know about the legal hassle.

  • Coronavirus vaccine update: AstraZeneca-Oxford trials not paused in India, says Serum Institute Sep 09, 2020 04:07 PM IST

    Coronavirus vaccine update: AstraZeneca-Oxford trials not paused in India, says Serum Institute

    Among coronavirus vaccines currently under development, the AstraZeneca-Oxford vaccine is seen as one of the most promising candidates.

  • COVID-19 vaccine: Serum Institute ties up with Gates Foundation, Gavi for 10 crore doses at Rs 225 each in India Aug 07, 2020 02:59 PM IST

    COVID-19 vaccine: Serum Institute ties up with Gates Foundation, Gavi for 10 crore doses at Rs 225 each in India

    For this, the Gates Foundation will provide an at-risk funding of $150 million to GAVI, with the pricing capped at a maximum of $3 per dose.

  • Exclusive: Poonawalla family's Serum Institute looks to raise $1 billion for big-ticket COVID-19 vaccine project Jun 26, 2020 04:39 PM IST

    Exclusive: Poonawalla family's Serum Institute looks to raise $1 billion for big-ticket COVID-19 vaccine project

    Investment banks Goldman Sachs, Citi and Avendus Capital have been engaged as advisors for the process by the privately held vaccine manufacturer, say sources.

  • Here is why horse breeding is the secret behind success of Cyrus Poonawalla's vaccine business Sep 11, 2019 05:13 PM IST

    Here is why horse breeding is the secret behind success of Cyrus Poonawalla's vaccine business

    With a net worth of $13 billion, Poonawalla is the fourth richest person in India and 100th in the world, according to Hurun Global Rich List - 2019.

  • Interview - Serum Institute's Adar Poonawala plans new vaccines and an NBFC Jul 05, 2018 02:10 PM IST

    Interview - Serum Institute's Adar Poonawala plans new vaccines and an NBFC

    Adar Poonawala took over from his father Cyrus, to guide the fortunes of the group. In an exclusive interview, he spoke about some of the group’s initiatives.

  • Looking for bigger partnership with Cipla: Serum Institute Jan 21, 2017 02:51 PM IST

    Looking for bigger partnership with Cipla: Serum Institute

    Adar Poonawala, CEO of Serum Institute, believes that a bigger partnership with Cipla will create a big Indian conglomerate. However, he added that the Cipla promoters currently have no plans for a merger and acquisition.

  • Cipla-Serum merger unlikely in near future: Adar Poonawala Jan 07, 2016 08:52 PM IST

    Cipla-Serum merger unlikely in near future: Adar Poonawala

    Serum Institute CEO Adar Poonawala has told CNBC-TV18 that Cipla and Serum will not be merging anytime soon. Cipla and Serum Institute have joined hands to sell products jointly across various countries in the world.

  • Clearances main worry, says Serum head on dengue antibody Sep 22, 2015 04:54 PM IST

    Clearances main worry, says Serum head on dengue antibody

    Serum Chief executive officer Adar Poonawalla says the company has entered into an exclusive agreement with US-based Visterra for developing a dengue antibody.

  • Serum's Cyrus Poonawala shares his journey to success Mar 26, 2015 07:22 PM IST

    Serum's Cyrus Poonawala shares his journey to success

    Winners of this years EY Entrepreneur of the Year 2014 Awards are an inspiration in themselves and to pay tribute to their triumphs we bring to you a very special series called Passion to Win. Our achiever today is responsible for the immunisation of 65 percent of the global infant population - Dr Cyrus Poonawala.

  • What a potential Cipla-Serum merger could mean Feb 06, 2015 05:16 PM IST

    What a potential Cipla-Serum merger could mean

    Billionnaire Cyrus Poonawalla, founder of the world‘s biggest vaccine maker Serum Institute, has told CNBC-TV18 that after the company tied up with drugmaker Cipla to sell its vaccines in Europe late last year, Serum is now exploring the option of merging with it.

  • Serum Institute to beat pharma giants with polio vaccine Sep 26, 2012 11:00 PM IST

    Serum Institute to beat pharma giants with polio vaccine

    CNBC-TV18's Archana Shukla finds out Poonawala‘s strategy that is winning him accolades in the world of vaccines.

  • Shantha Biotech to launch 5-in-1 pediatric vaccine Mar 27, 2012 10:43 PM IST

    Shantha Biotech to launch 5-in-1 pediatric vaccine

    The world of pediatric vaccines is about to be shaken. And it's Hyderabad based Shantha Biotech that's going to do all the shaking

Sections
ISO 27001 - BSI Assurance Mark